| 0 |
Actinomycin [EPC] |
1 |
0.0005 |
| 1 |
Iron Chelator [EPC] |
3 |
0.0001 |
| 2 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 3 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
1 |
0.0001 |
| 4 |
Alkylating Drug [EPC] |
17 |
0.0001 |
| 5 |
Topoisomerase Inhibitor [EPC] |
5 |
0.0001 |
| 6 |
Non-narcotic Antitussive [EPC] |
1 |
0.0001 |
| 7 |
Antimetabolite Immunosuppressant [EPC] |
1 |
0.0000 |
| 8 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
6 |
0.0000 |
| 9 |
Microtubule Inhibitor [EPC] |
6 |
0.0000 |
| 10 |
Pyridone [EPC] |
1 |
0.0000 |
| 11 |
Parathyroid Hormone Analog [EPC] |
2 |
0.0000 |
| 12 |
Proteasome Inhibitor [EPC] |
2 |
0.0000 |
| 13 |
Calcium [EPC] |
2 |
0.0000 |
| 14 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 15 |
Retinoid [EPC] |
3 |
0.0000 |
| 16 |
Folate Analog Metabolic Inhibitor [EPC] |
5 |
0.0000 |
| 17 |
Platinum-based Drug [EPC] |
3 |
0.0000 |
| 18 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 19 |
RANK Ligand Inhibitor [EPC] |
2 |
0.0000 |
| 20 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 22 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Thalidomide Analog [EPC] |
3 |
0.0000 |
| 24 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 25 |
Platelet Aggregation Inhibitor [EPC] |
2 |
0.0000 |
| 26 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 27 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 28 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 29 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 30 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 31 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 32 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 33 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |